Krka, d. d. Krka, d. d.

Krka, d. d.

KRK

Rangering i aksjer #2136
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
Aksjekurs
$315.87
Markedsverdi
$9.56B
Endring (1 dag)
0.90%
Endring (1 år)
28.29%
Land
SI
Handel Krka, d. d. (KRK)

Kategori

Healthcare
Historikk for aksjesplitt for Krka, d. d. (KRK)
Aksjen Krka, d. d. (symbol: KRK) har gjennomgått totalt 1 aksjesplitt.
Den nyeste splittelsen skjedde Sep 03, 2007.
Én KRK-aksje kjøpt før Sep 03, 2007 tilsvarer i dag 10 KRK-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
2007-09-03 10:1 x10 x10
Aksjesplitt for lignende selskaper eller konkurrenter